Bioactive tricalcium silicate/alginate composite bone cements with enhanced physicochemical properties.

Tricalcium silicate has been recognized for its bioactive properties and suitable degradation rate in bone cement applications. However, limitations like poor washout resistance, formability, and injectability have restricted its clinical use. Prior research has established these properties but has not resolved the mechanical and handling issues. This gap motivated the development of composite materials that maintain bioactivity while enhancing physical performance. The need for injectable and moldable bone cements remains unmet in current clinical settings. Researchers have explored various additives to improve these properties, but none have achieved optimal results. The interaction between calcium ions and sodium alginate has not been fully explored in this context. This study addresses the unresolved challenge of improving mechanical and handling characteristics without compromising bioactivity. The findings aim to bridge the gap between material science and clinical orthopedic needs.

This study aimed to improve tricalcium silicate's limitations by creating a composite with sodium alginate. The goal was to enhance washout resistance, formability, and injectability while maintaining bioactivity. The researchers proposed using the interaction between calcium ions and alginate molecules to form a double-network structure. This approach was intended to improve mechanical and handling properties. The study sought to test whether sodium alginate could effectively modify tricalcium silicate's behavior. The researchers focused on optimizing the composite's composition for maximal performance. They aimed to confirm that the composite could achieve higher compressive strength than pure tricalcium silicate. The results would provide evidence for the composite's suitability as a bone repair material.

The researchers combined tricalcium silicate with sodium alginate to form a composite. They utilized the interaction between calcium ions and alginate molecules to build a double-network structure. The composite was analyzed for washout resistance, formability, and injectability. Compressive strength was measured using standard mechanical testing protocols. The bioactivity of the composite was assessed by its ability to induce apatite formation in simulated body fluid. Cell proliferation tests were conducted to evaluate biological compatibility. The researchers compared the composite's properties with pure tricalcium silicate. The study focused on determining the optimal composition for maximal performance.

The composite showed significantly improved washout resistance, formability, and injectability compared to pure tricalcium silicate. The compressive strength of the composite reached 54 MPa, which is higher than the 35.3 MPa of pure tricalcium silicate. The double-network structure contributed to these mechanical improvements. The composite retained the bioactivity of tricalcium silicate, including apatite formation in simulated body fluid. Cell proliferation was enhanced in the presence of the composite material. The optimal composition demonstrated the best balance of properties. The results suggest that the composite outperforms pure tricalcium silicate in key performance metrics. These findings support the composite's potential for further in vitro and in vivo studies.

The study's findings suggest that the tricalcium silicate/sodium alginate composite improves mechanical and handling properties without compromising bioactivity. The composite's washout resistance, formability, and injectability were significantly enhanced. The compressive strength of the composite was notably higher than that of pure tricalcium silicate. The double-network structure formed by calcium ions and alginate molecules contributed to these improvements. The composite retained the ability to induce apatite formation and promote cell proliferation. These results indicate that the composite holds promise as a new type of bone repair material. The authors propose that further in vitro and in vivo studies are warranted to confirm clinical suitability. The findings support the composite's potential for future orthopedic applications.